Kesong Peng
Shanghai, 200032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Histone Demethylase JMJD2D: A Novel Player in Colorectal and Hepatocellular Cancers.
Journal: Cancers
Published: April 18, 2022
Correction to: Histone demethylase JMJD2D activates HIF1 signaling pathway via multiple mechanisms to promote colorectal cancer glycolysis and progression.
Journal: Oncogene
Published: February 23, 2021
The Ubiquitin E3 Ligase TRIM21 Promotes Hepatocarcinogenesis by Suppressing the p62-Keap1-Nrf2 Antioxidant Pathway.
Journal: Cellular and molecular gastroenterology and hepatology
Published: September 29, 2020
Histone demethylase JMJD2D activates HIF1 signaling pathway via multiple mechanisms to promote colorectal cancer glycolysis and progression.
Journal: Oncogene
Published: May 25, 2020
Histone Demethylase JMJD2D Interacts With β-Catenin to Induce Transcription and Activate Colorectal Cancer Cell Proliferation and Tumor Growth in Mice.
Journal: Gastroenterology
Published: January 30, 2018
Histone demethylase JMJD1A promotes colorectal cancer growth and metastasis by enhancing Wnt/β-catenin signaling.
Journal: The Journal of biological chemistry
Published: January 04, 2018
Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α.
Journal: Oncogene
Published: August 11, 2016
Showing 1-11 of 11
Last Updated: 09/26/2026